References
Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219. doi:10.1093/eurheartj/eht151
Cushman WC, Evans GW, Byington RP et al (2010) Effects of intensive blood-pres- sure control in type 2 diabetes mellitus. N Engl J Med 362:1575–1585
Xie X, Atkins E, Lv J et al (2016) Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet 387:435–443
The SPRINT Research Group (2015) A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 373:2103–2116
Bassler D, Briel M, Montori VM et al (2010) Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 303(12):1180–1187
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of human and animal rights
Our cutting edge doesn't involve human beings or animals.
Informed consent
There was no need of informed consent.
Rights and permissions
About this article
Cite this article
Cernuschi, G., Fiorelli, E.M. & GrAM (Gruppo di Autoformazione metodologica). New blood pressure goals for patients with increased cardiovascular risk. Intern Emerg Med 11, 753–754 (2016). https://doi.org/10.1007/s11739-016-1477-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-016-1477-8